Allopurinol may cut risk for neurodegenerative diseases
May 19, 2023
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
FDA approves first drug meant to ease Alzheimer’s disease-llnked agitation
May 11, 2023
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo.
Experimental drug for Alzheimer’s disease slows decline in thinking
May 03, 2023
Eli Lilly says the drug slows memory and thinking declines in early symptomatic Alzheimer’s disease patients by more than a third.
Women have higher tau, especially in setting of elevated Aβ
Apr 05, 2023
Later age at menopause and hormone therapy non-use also were associated with higher regional tau.
Atrial fibrillation may increase risk for dementia
Mar 10, 2023
The risk was more prominent in younger patients and those without chronic kidney disease.
Vitamin D supplementation may cut dementia incidence
Mar 08, 2023
Any vitamin D supplement exposure was associated with a 40% lower dementia incidence.
High cardiovascular health tied to longer life expectancy free of disease
Mar 06, 2023
For those with high cardiovascular health level, no significant difference was seen in disease-free life expectancy based on socioeconomic status.
AAN: Higher scores on life’s simple 7 linked to lower dementia risk in women
Mar 01, 2023
For women, a higher AHA Life’s Simple 7 score at baseline in midlife is linked to a reduced risk for later-life dementia.
Regular use of laxatives linked to risk for all-cause dementia
Feb 23, 2023
Risk for all-cause, vascular dementia was increased with number of regularly used laxative types
Alzheimer’s research, treatments prioritized in 2 bills taken up by Congress
By
Kimberly Bonvissuto
Feb 06, 2023
Two bipartisan bills prioritizing Alzheimer’s research and supporting scientists in the development of treatments for the disease were reintroduced in Congress last week.